Showing 1 - 1 of 1
The administration of (biologically-derived) drugs for various disease conditions involves consumption of resources that constitutes a direct monetary cost to healthcare payers and providers. An often ignored cost relates to a mismatch between patients' preferences and the mode of drug...
Persistent link: https://www.econbiz.de/10012010734